Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Optimal Biomarker-Guided Design for Targeted Therapy with Imperfectly Measured Biomarkers Read chapter Read first chapter

2016 | OriginalPaper | Chapter

A Statistical Model for Risk-Based Monitoring of Clinical Trials

Author : Gregory J. Hather

Published in: Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Risk-based monitoring allows monitors of clinical trial sites to focus their visits on sites with the greatest potential for risk reduction. Here we present a statistical model that recommends sites for the monitor to visit. The model makes use of a pre-visit assessment supplied by the monitor, as well as other measurable factors, to predict the monitor’s post-visit assessment of the risk reduction resulting from the visit. The monitor is then directed to visit the sites with the highest predicted risk reduction. We demonstrate the properties of this model using a simulation. Our simulation compares two strategies for directing monitors, one of which relies on the model, while the other strategy relies only on the monitor’s pre-visit assessments. Our simulation demonstrates that the model-based strategy can direct the monitors to sites with greater potential for risk reduction. Finally, we discuss alternative models as well as potential pitfalls of risk-based monitoring.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter Some Misconceptions on the Use of Composite Endpoints
next chapter Blinded Safety Signal Monitoring for the FDA IND Reporting Final Rule
Literature
Williams, G.W., 2006. The other side of clinical trial monitoring; assuring data quality and procedural adherence. Clinical Trials, 3(6), pp.530-537.
Morrison, B.W., Cochran, C.J., White, J.G., Harley, J., Kleppinger, C.F., Liu, A., Mitchel, J.T., Nickerson, D.F., Zacharias, C.R., Kramer, J.M. and Neaton, J.D., 2011. Monitoring the quality of conduct of clinical trials: a survey of current practices. Clinical Trials, 8(3), pp.342-349.
Bhatt, A., 2011. Quality of clinical trials: A moving target. Perspectives in clinical research, 2(4), p.124.
Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring. U.S. Department of HHS, FDA, August 2013 OMB Control No. 0910–0733.
Hullsiek, K.H., Kagan, J.M., Engen, N., Grarup, J., Hudson, F., Denning, E.T., Carey, C., Courtney-Rodgers, D., Finley, E.B., Jansson, P.O. and Pearson, M.T., 2015. Investigating the Efficacy of Clinical Trial Monitoring Strategies Design and Implementation of the Cluster Randomized START Monitoring Substudy. Therapeutic innovation & regulatory science, 49(2), pp.225-233.
Franco, P., Hronec, M. and Karacsony, A., 2013. Risk-based monitoring: Reduce clinical trial costs while protecting safety and quality. PricewaterhouseCoopers.
Burgess, M. and ICONIK, I., 2013. Less is more: risk-based monitoring of site performance. ICON Insight, 13.
Reflection paper on risk based quality management in clinical trials. European Medicines Agency. 18 November 2013 EMA/269011/2013.
Timmermans, C., Doffagne, E., Venet, D., Desmet, L., Legrand, C., Burzykowski, T. and Buyse, M., 2016. Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial. Gastric Cancer, 19(1), pp.24-30.
Desmet, L., Venet, D., Doffagne, E., Timmermans, C., Burzykowski, T., Legrand, C. and Buyse, M., 2014. Linear mixed‐effects models for central statistical monitoring of multicenter clinical trials. Statistics in medicine, 33(30), pp.5265-5279.
Venet, D., Doffagne, E., Burzykowski, T., Beckers, F., Tellier, Y., Genevois-Marlin, E., Becker, U., Bee, V., Wilson, V., Legrand, C. and Buyse, M., 2012. A statistical approach to central monitoring of data quality in clinical trials. Clinical Trials, 9(6), pp.705-713.
Timmermans, C., Venet, D. and Burzykowski, T., 2015. Data-driven risk identification in phase III clinical trials using central statistical monitoring. International journal of clinical oncology, pp.1-8.
Zink, R.C., 2014. Risk-based monitoring and fraud detection in clinical trials using JMP and SAS. SAS Institute.
Taylor, R.N., McEntegart, D.J. and Stillman, E.C., 2002. Statistical techniques to detect fraud and other data irregularities in clinical questionnaire data. Drug information journal, 36(1), pp.115-125.
Buyse, M., George, S.L., Evans, S., Geller, N.L., Ranstam, J., Scherrer, B., Lesaffre, E., Murray, G., Edler, L., Hutton, J. and Colton, T., 1999. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Statistics in medicine, 18(24), pp.3435-3451.
Al-Marzouki, S., Evans, S., Marshall, T. and Roberts, I., 2005. Are these data real? Statistical methods for the detection of data fabrication in clinical trials. Bmj, 331(7511), pp.267-270.
George, S.L. and Buyse, M., 2015. Data fraud in clinical trials. Clinical investigation, 5(2), pp.161-173.
Tantsyura, V., Dunn, I.M., Fendt, K., Kim, Y.J., Waters, J. and Mitchel, J., 2015. Risk-Based Monitoring A Closer Statistical Look at Source Document Verification, Queries, Study Size Effects, and Data Quality. Therapeutic Innovation & Regulatory Science, 49(6), pp.903-910.
Nielsen, E., Hyder, D. and Deng, C., 2013. A data-driven approach to risk-based source data verification. Therapeutic Innovation & Regulatory Science, p.2168479013496245.
van den Bor, R.M., Oosterman, B.J., Oostendorp, M.B., Grobbee, D.E. and Roes, K.C., 2016. Efficient Source Data Verification Using Statistical Acceptance Sampling A Simulation Study. Therapeutic Innovation & Regulatory Science, 50(1), pp.82-90.
DeMars, C. (2010). Item Response Theory. Oxford, UK: Oxford University Press.
Crawley, M. J. (2012) Mixed-Effects Models, in The R Book, Second Edition, John Wiley & Sons, Ltd, Chichester, UK.
Rabiner, L.R. and Juang, B.H., 1986. An introduction to hidden Markov models. ASSP Magazine, IEEE, 3(1), pp.4-16.
Rubin, D.B., 1976. Inference and missing data Biometrika 63 (3): 581–592. Find this article online.
Power, D.J., Sharda, R. and Burstein, F., 2015. Decision support systems. John Wiley & Sons, Ltd.
Khan, F.I. and Haddara, M.M., 2003. Risk-based maintenance (RBM): a quantitative approach for maintenance/inspection scheduling and planning. Journal of Loss Prevention in the Process Industries, 16(6), pp.561-573.
Thomas, L.C., 2000. A survey of credit and behavioural scoring: forecasting financial risk of lending to consumers. International journal of forecasting, 16(2), pp.149-172.
Metadata
Title
A Statistical Model for Risk-Based Monitoring of Clinical Trials
Author
Gregory J. Hather
Copyright Year
2016
Book
Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics

Print ISBN: 978-3-319-42567-2

Electronic ISBN: 978-3-319-42568-9

Copyright Year: 2016

DOI
https://doi.org/10.1007/978-3-319-42568-9_16

Premium Partner

    Image Credits